Literature DB >> 26586397

The construction and proliferative effects of a lentiviral vector capable of stably overexpressing SPINK1 gene in human pancreatic cancer AsPC-1 cell line.

Jing Zhang1, Dongmei Wang2, Na Hu1, Qian Wang3, Shanice Yu3, Jun Wang4.   

Abstract

This study aims to design and generate recombinant lentiviral vector containing the complete coding sequence (CDS) region of human serine protease inhibitor Kazal type 1 gene (SPINK1) and establish a human pancreatic cancer cell line (AsPC-1) stably overexpressing SPINK1. Then, to assess the proliferative and oncogenic effects of upregulated SPINK1 gene on pancreatic cancer AsPC-1 cells using different methods. Initially, the target coding sequence (CDS) of SPINK1 was amplified by polymerase chain reaction (PCR) and the synthesized product was subsequently subcloned into the lentiviral vector. The construction of recombinant SPINK1 gene was verified by the restriction digestion and sequencing analysis. The lentiviral particles carrying SPINK1 gene were produced by co-transfection of the recombination lentiviral vector and the packaging mix plasmids into 293 T cells and filtered and concentrated before AsPC-1 cells were infected by the virus particles. The cells transduced were differentially selected with puromycin, and the clones that highly expressed SPINK1 were chosen by real-time PCR and confirmed by Western blot after 7 weeks. The stably transduced AsPC-1 cell line showed significantly increased metabolic and proliferative capability using CCK-8 and Trypan Blue assays (P < 0.001). Cell cycle and DNA content analysis by flow cytometry showed that upregulated SPINK1 elicited significant increase in the percentage of AsPC-1 cells in the S and G2/M phase (P < 0.001). Clone formation assay demonstrated that the number of the colonies formed in the experimental group was greater than that in the control parental cells (P < 0.001). It was concluded that a stable AsPC-1 cell line capable of overexpressing SPINK1 had been successfully created, and that the proliferative capacity of AsPC-1 pancreatic cancer cells was significantly raised by SPINK1 upregulation as well as the ability of a single AsPC-1 cell to grow into a colony.

Entities:  

Keywords:  Lentiviral vector; Pancreatic cancer; Proliferation; Serine protease inhibitor Kazal type 1 (SPINK1)

Mesh:

Substances:

Year:  2015        PMID: 26586397     DOI: 10.1007/s13277-015-4405-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

Review 1.  The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach.

Authors:  R E Favoni; A de Cupis
Journal:  Pharmacol Rev       Date:  2000-06       Impact factor: 25.468

Review 2.  Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls.

Authors:  Mohan Babu Appaiahgari; Sudhanshu Vrati
Journal:  Expert Opin Biol Ther       Date:  2014-12-22       Impact factor: 4.388

Review 3.  Novel targets in pancreatic cancer research.

Authors:  Geoffrey Kozak; Fernando F Blanco; Jonathan R Brody
Journal:  Semin Oncol       Date:  2014-12-10       Impact factor: 4.929

Review 4.  Experimental design for stable genetic manipulation in mammalian cell lines: lentivirus and alternatives.

Authors:  Robert F Shearer; Darren N Saunders
Journal:  Genes Cells       Date:  2014-10-13       Impact factor: 1.891

5.  Pancreatic cancer incidence and mortality patterns in China, 2011.

Authors:  Yutong He; Rongshou Zheng; Daojuan Li; Hongmei Zeng; Siwei Zhang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2015-02       Impact factor: 5.087

6.  Overexpression of pancreatic secretory trypsin inhibitor in pancreatic cancer. Evaluation of its biological function as a growth factor.

Authors:  Y Ohmachi; A Murata; N Matsuura; T Yasuda; K Uda; T Mori
Journal:  Int J Pancreatol       Date:  1994-02

7.  Pancreatic secretory trypsin inhibitor causes autocrine-mediated migration and invasion in bladder cancer and phosphorylates the EGF receptor, Akt2 and Akt3, and ERK1 and ERK2.

Authors:  Tania Marchbank; Asif Mahmood; Raymond J Playford
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-22

Review 8.  Cell proliferation and cancer.

Authors:  J F López-Sáez; C de la Torre; J Pincheira; G Giménez-Martín
Journal:  Histol Histopathol       Date:  1998-10       Impact factor: 2.303

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  Identification and characterization of receptors specific for human pancreatic secretory trypsin inhibitor.

Authors:  T Niinobu; M Ogawa; A Murata; J Nishijima; T Mori
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  4 in total

1.  Role of keratin 24 in human epidermal keratinocytes.

Authors:  Min Min; Xi-Bei Chen; Ping Wang; Lilla Landeck; Jia-Qi Chen; Wei Li; Sui-Qing Cai; Min Zheng; Xiao-Yong Man
Journal:  PLoS One       Date:  2017-03-31       Impact factor: 3.240

2.  CIAPIN1 Targeted NHE1 and ERK1/2 to Suppress NSCLC Cells' Metastasis and Predicted Good Prognosis in NSCLC Patients Receiving Pulmonectomy.

Authors:  Jian Wang; Ying Zhou; Li Ma; Shannan Cao; Wei Gao; Qingqing Xiong; Kaiyuan Wang; Lili Yang
Journal:  Oxid Med Cell Longev       Date:  2019-04-09       Impact factor: 6.543

Review 3.  Functional Roles of SPINK1 in Cancers.

Authors:  Tsung-Chieh Lin
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

4.  Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.

Authors:  Jianlong Jia; Latai Ga; Yang Liu; Zhiyi Yang; Yue Wang; Xuanze Guo; Ruichen Ma; Ruonan Liu; Tianyou Li; Zeyao Tang; Jun Wang
Journal:  Front Immunol       Date:  2022-07-18       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.